Terns to Present at the Cowen 41st Annual Health Care Conference

Rhea-AI Summary

Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage biopharmaceutical company, announced its participation in the Cowen 41st Annual Health Care Conference. Management will present on March 4 at 9:50 a.m. ET, with a live audio webcast available on their website. Additionally, Terns will join a NASH panel discussion on March 2 from 12:50-1:50 p.m. ET. The company focuses on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and chronic liver diseases.

FOSTER CITY, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today announced that management will be presenting at the Cowen 41st Annual Health Care Conference on Thursday, March 4 at 9:50 a.m. ET.

A live audio webcast of the presentation will be available here and on Terns’ website at http://ir.ternspharma.com/. A replay of the webcast will be archived on Terns’ website for 30 days following the presentation.

Terns will also participate in a NASH panel at the conference on Tuesday, March 2 from 12:50-1:50 p.m. ET.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. For more information, please visit www.ternspharma.com.

US Media Contact:
Investor Relations Contact:
Mark Vignola
investors@ternspharma.com

Media Contact:
Cory Tromblee
media@ternspharma.com

FAQ

When will Terns Pharmaceuticals present at the Cowen 41st Annual Health Care Conference?

Terns Pharmaceuticals will present on March 4 at 9:50 a.m. ET.

What is the focus of Terns Pharmaceuticals' research?

Terns Pharmaceuticals focuses on developing therapies for non-alcoholic steatohepatitis (NASH) and chronic liver diseases.

When is the NASH panel discussion featuring Terns Pharmaceuticals?

The NASH panel discussion will take place on March 2 from 12:50-1:50 p.m. ET.

How can I access the live webcast of Terns Pharmaceuticals' presentation?

The live audio webcast can be accessed on Terns' website during the presentation.

What is the stock symbol for Terns Pharmaceuticals?

The stock symbol for Terns Pharmaceuticals is TERN.